Skip to main content
. 2022 Jul 21;101(9):978–986. doi: 10.1111/aogs.14407

TABLE 2.

Adverse events

Surgery number AE Days after procedure Seriousness (AE/SAE) CDC grade Converted Relatedness to device Expectedness
41 Acute urinary tract infection 16 SAE II No Not related Expected
43 Vaginal bleeding 25 SAE IIIb No Related Expected
Left ureteric duplication requiring later surgery 74 SAE IIIb Not related Expected
63 Breathlessness 1 SAE IVa No Not related Expected
88 Urinary tract infection 15 AE II No Not related Expected
Tingling sensation in both lower limbs 25 AE II Not related Unexpected
Lower backache radiating to both lower limbs 25 AE II Not related Expected
103 Burning sensation in epigastric region 5 AE I No Not related Expected
Dysuria and increased frequency of micturition 9 AE II Not related Expected
Pain in lower abdomen 10 AE I Not related Expected
107 Breathlessness <1 SAE IVa No Not related Expected
Diabetic ketoacidosis 3 SAE IVa Not related Expected
117 Urinary bladder injury Intra‐operative SAE NA Conventional laparoscopy Not related Expected

Abbreviations: AE, adverse event; CDC, Clavien–Dindo classification 27 ; NA, not applicable; SAE, serious adverse event.